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Abstract
Purpose: Status after sclerotherapy constitutes a good clinical model for venous thrombosis with known age. The aim 
of this study was to compare elastographic parameters of material obliterating the great saphenous vein at 7-21 days 
after polidocanol sclerotherapy.
Material and methods: The study included 60 patients subjected to sclerotherapy due to venous insufficiency (45 women 
and 15 men, mean age 51.2 ± 14.7 years, range 27-77 years). Elastographic parameters of obliterating material: total 
area of vessel cross-section (mm2), relative areas (%) covered by tissues with highest, intermediate, and lowest elastici-
ty, were determined 7 ± 1, 14 ± 2, and 21 ± 2 days post-sclerotherapy, respectively. Mean time to partial and complete 
organisation of the obliterating material was estimated during probit regression analysis. 
Results: The relative area of vessel cross-section covered by tissues with the lowest elasticity underwent a statistically 
significant enlargement, either between the first and the second (Z = 6.725, p < 0.001) or between the second and the 
third control visit (Z = 6.717, p < 0.001). This corresponded to a change in the structure of the obliterating material 
from elastic during the first visit (in all patients) to mixed (fibro-elastic) or fibrous during the third visit (71.7% and 
28.3% of patients, respectively). Mean time after which the obliterating material reached mixed and fibrous structure 
on elastographic images was estimated at 14.3 days and > 21 days, respectively.
Conclusions: Ultrasound elastography may accurately reflect the age of venous thrombosis in polidocanol sclerother-
apy model. Mixed, fibro-elastic structure of a 14-day-old obliterating material visualised by elastography probably 
corresponds with chronic thrombus.
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Introduction
Venous thrombosis and its complications, in particular 
pulmonary embolism, constitute a significant clinical 
problem. Incidence of venous thrombosis is estimated at 
1 per 1000 per year in the general population [1], but may 
increase up to five per 1000 per year among subjects older 
than 70 years [2]. Pulmonary embolism is diagnosed in 
40-60% of patients with venous thrombosis [3] and may 
contribute to up to 10% of deaths occurring during hos-
pitalisation [4,5].
The principal goal of primary treatment in venous 
thrombosis is to prevent further enlargement of the throm-
bus and reduce the risk of potentially fatal pulmonary 
embolism [6]. Age of thrombosis is a key factor driving 
therapeutic decisions in patients with venous thrombosis. 
Early, elastic thrombi are loosely bound to the vascular wall 
and therefore can be easily detached and become a cause of 
pulmonary embolism. On the other hand, early thrombo-
sis responds well to treatment with heparins and oral an-
ticoagulants; furthermore, it is associated with lower risk 
of vascular injury during a thrombectomy procedure [7,8]. 
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In turn, older thrombi contain a larger proportion of 
fibrous elements and are more tightly bound to the vas-
cular wall; this is reflected by markedly lower risk of pul-
monary embolism. In such cases, treatment, either phar-
macological or surgical, is usually unnecessary or even not 
recommended due to risk of bleeding after administration 
of heparins or post-thrombectomy vascular injury [9].
In a clinical setting, age of thrombosis is estimated on 
the basis of symptoms, history data, results of conventional 
ultrasonography, and other imaging studies [10]. However, 
clinical presentation of venous thrombosis is highly het-
erogeneous, and some cases may be even asymptomatic 
[11-13]. Moreover, conventional compression ultrasonog-
raphy with duplex scanning and colour Doppler, despite 
more than 95% sensitivity, specificity, and positive and 
negative predictive value in detection of venous throm-
bosis [14], is not suitable for distinguishing between acute 
and chronic thrombi [7,15]. All these factors contributed 
to growing interest in ultrasound elasto graphy as a po-
tential method to estimate the age of venous thrombosis.
Ultrasonographic elastography is a relatively new 
method of diagnostic imaging, providing information on 
the “hardness” of tissues independently of their acoustic 
impedance and vascular flows [16]. Examination is based 
on the assumption that each tissue has its specific elas-
ticity; this parameter can be used to distinguish between 
various tissues and, most importantly, to differentiate 
between physiological and pathological processes [17]. 
Mechanical properties of tissues are evaluated based on 
their deformity under an applied force. The softer the 
tissue, the greater its deformity, and vice versa. The most 
commonly used type of elastography in clinical practice 
is real-time quasi-static elastography, so-called freehand 
elastography. Elastographic images of examined tissues 
are obtained in two stages, prior to and after controlled 
compression [18], processed digitally, and presented in 
the form of an elastogram. The latter is a colour map on 
which differently coloured regions correspond to tissues 
with various hardness. Typically, elastic tissues are pre-
sented as red areas, whereas those with intermediate and 
low elasticity are presented as green and blue, respec-
tively [19]. Such an elastogram is subject to a semiquan-
titative analysis, i.e. comparison with a reference colour 
scale or determination of tissue strain ratio (SR). SR is 
calculated as the ratio of the deformation in the region 
of interest to the deformation of an adjacent reference 
region [18].
Available evidence suggests that dynamics of changes 
in the structure of venous thrombi in patients with throm-
bosis can be reflected on elastographic images. However, 
the number of previous studies dealing with the problem 
in question is fairly limited; apart from four [14,20-22], 
they dealt solely with animal or ex vivo models [23-27]. 
Nevertheless, these studies demonstrated that the hard-
ness of venous thrombi increases with their age, and their 
elastographic parameters correspond well with the mi-
croscopic structure of vessel histopathologic specimens. 
However, the results of published studies are still incon-
clusive owing a plethora of used elastographic techniques 
and experimental models, as well as a relatively low statis-
tical power. Furthermore, we still do not know whether, 
and based on which elastographic parameters, one can 
differentiate between acute venous thrombosis qualifying 
for primary anticoagulant therapy and older lesions, in 
the case of which, treatment should be aimed primarily at 
prevention of recurrent thrombosis and/or post-throm-
botic syndrome.
Status after injection of a sclerosant, polidocanol, was 
shown to closely resemble venous thrombosis [28]. Scle-
rotherapy is an established treatment for venous insuffi-
ciency. During this procedure, injection of sclerosant con-
tributes to chemical ablation of the affected vessel: lysis 
of thrombocytes and erythrocytes, and degradation of li-
pids and phospholipids in vascular endothelium. Chang-
es in blood morphology and endothelial injury result in 
hypercoagulability, and eventually promote local throm-
bosis. Sclerotherapy model can be used to obtain a highly 
heterogeneous group of patients with venous thrombosis 
of known age. In this study, we applied such a model to 
compare elastographic parameters of material obliterating 




The study, conducted between October 2016 and Janu-
ary 2017, included 60 patients with venous insufficiency, 
subjected to sclerotherapy at the Centre of Phlebology in 
Warsaw (Poland), 45 women and 15 men (mean age 51.2 
± 14.7 years, range 27-77 years). Inclusion criteria of the 
study were: 1) age > 18 years, 2) written, informed consent 
to participate, and 3) qualification for sclerotherapy of 
great saphenous vein; the vein must have been 3-5 mm in 
diameter, fully competent, or after partial proximal phle-
bectomy. The list of exclusion criteria contained the fol-
lowing: 1) history of thrombosis in great saphenous vein, 
2) presence of potential risk factors for venous thrombosis 
(malignancy, predisposing genetic mutation, skin lesions 
in area drained by the great saphenous vein), 3) anato-
mic factor precluding adequate visualisation of the vein, 
4) evidence of recanalisation during one of the control 
visits, and 5) incomplete follow-up documentation.
Study protocol
The study included four visits – the first visit (sclerothera-
py) followed by three control visits: 1) 7 ± 1 days, 2) 14 ± 2 
days, and 3) 21 ± 2 days after the procedure.
The aim of sclerotherapy, performed independently of 
this study, was to obliterate great saphenous vein during 
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the course of venous insufficiency. Qualification to treat-
ment and the procedure itself were always carried out by 
the same vascular surgeon. The first stage of sclerother-
apy was generation of foam, made of a sclerosant, po-
lidocanol (Aetoxysklerol; Kreussler Pharma, Germany), 
mixed with respiratory gases in a 1 : 4 ratio (0.5 ml of ac-
tive sclerosant per 2 ml of respiratory gases). The mixture 
was prepared with the aid of a 2-ml syringe, three-way 
adaptor, and another 5-ml syringe. The foam was gener-
ated by pushing the plunger of the larger syringe 30 times 
and pumping its contents to the smaller syringe. Immedi-
ately thereafter, the foam was injected to the great saphe-
nous vein, 30 cm from the saphenofemoral junction, via 
a 0.45 x 16 26G x 5/8 needle. The sclerosant was admin-
istered slowly, using low pressure and under ultrasono-
graphic control.
During each control visit, all patients were subjected to 
elastographic examination with the same MyLabTMTwice 
(Esaote SpA, Italy) ultrasonograph equipped with a linear 
vascular probe, type LA533. The obliterated vessel was ex-
amined in a longitudinal elastographic view (no diagnos-
tic images were obtained in a transverse view) 30 cm from 
the saphenofemoral junction. To obtain the elastogram, the 
vein was compressed rhythmically, approximately twice 
per second. Correctness of the elastogram was verified 
against a colour pattern displayed at the side of the screen. 
The list of analysed parameters included total area of vessel 
cross-section (mm2), as well as the relative areas (%) cov-
ered by tissues the with highest, intermediate, and lowest 
elasticity, highlighted in on the elastograms with red, green, 
and blue, respectively.
Statistical analysis
Normal distribution of analysed continuous variables was 
verified with Shapiro-Wilk test, and their statistical char-
acteristics were presented as arithmetic means, standard 
deviations, medians, and ranges. Distributions of discrete 
variables were presented as numbers and percentages. 
The significance of differences in the values of quantitative 
variables determined during consecutive control visits was 
verified with Friedman ANOVA and Wilcoxon post-hoc 
test. Distributions of discrete variables during consecutive 
visits were compared with Pearson chi-squared test and 
Fisher exact test. During the last stage of the analysis, we 
used probit regression models to estimate time to partial 
and complete organisation of the obliterating material. 
The aim of probit regression analysis is to identify the val-
ue of an explanatory variable (in this case, follow-up time) 
at which the study endpoint (in this case, partial or com-
plete organisation of obliterating material) was achieved 
by 50% of the study subjects. All statistical calculations 
were carried out with Statistica 10 package (StatSoft, Unit-
ed States), with the threshold of statistical significance set 
at p ≤ 0.05.
Results
None of the study subjects showed recanalisation of the 
obliterating material during consecutive control visits. 
Statistical characteristics of elastographic findings are 
presented in Table 1. The area of vessel cross-section did 
not change significantly from visit to visit (Z = 1.405, 
p = 0.495). In turn, the relative area covered by tissues 
highlighted in red (R) decreased significantly, either be-
tween the first and the second (Z = 6.736, p < 0.001) or 
between the second and third control visit (Z = 6.518, 
p < 0.001). In contrast, the relative area covered by tissues 
highlighted in green (G) increased significantly between 
the first and the second visit (Z = 4.278, p < 0.001) and 
then underwent a statistically significant reduction be-
tween the second and the third visit (Z = 5.419, p < 0.001). 
Total relative area covered by tissues highlighted in red or 
green (R+G) decreased significantly both between the first 
and the second (Z = 6.729, p < 0.001) and between the 
second and the third visit (Z = 6.717, p < 0.001). Finally, 
the relative area covered by tissues highlighted in blue (B) 
underwent a statistically significant enlargement, either 
between the first and the second (Z = 6.725, p < 0.001) or 
between the second and the third control visit (Z = 6.717, 
p < 0.001).
Based on the relative area covered by tissues high-
lighted in blue (B), obliterating material was classified as: 
1) elastic – for B < 33%, 2) mixed – for B ≥ 33% but 
< 66%, or 3) fibrous – for B ≥ 66% (Figure 1). Based on 
the abovementioned criteria, material obliterating the great 
saphenous vein during the first control visit was classified 
as elastic in all cases. Using the same criteria, elastographic 
Table 1. Statistical characteristics of elastographic parameters determined during consecutive control visits
Parameter Visit 1 (7 ± 1 days) Visit 2 (14 ± 2 days) Visit 3 (21 ± 2 days)
Vessel area (mm2) 85.5 (31-160) 81.0 (41-204) 86.5 (41-234)
R (%) 56.5 (39-76) 20.0 (0-38) 3.0 (0-28)
G (%) 39.5 (20-55) 50.5 (17-78) 37.5 (7-59)
R+G (%) 96.0 (89-100) 70.5 (33-95) 40.0 (7-64)
B (%) 4.0 (0-11) 29.5 (3-67) 60.0 (37-93)
R, G, B – relative areas of vascular cross-section highlighted in red, green, and blue. 
Results presented as medians (ranges).
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structure of obliterating material during the second visit 
was classified as elastic in 36 (60.0%) patients, mixed in 
23 (38.3%), and fibrous in one (1.7%). During the third 
visit, the structure of the obliterating material was mixed 
in 43 (71.7%) subjects and fibrous in 17 (28.3%). The pro-
portion of patients in whom the structure of obliterating 
material was classified as mixed increased between the 
first and the second visit (χ2 = 30.000, p < 0.001). In turn, 
between the second and the third control visit, a statisti-
cally significant increase was observed in the percentage 
of patients with mixed or fibrous structure of obliterating 
material (χ2 = 56.283, p < 0.001).
Probit regression analysis demonstrated that the 
mean time after which obliterating material reached 
mixed, fibro-elastic structure on elastographic images was 
14.3 days (Figure 2). Because only 28.3% of participants 
reached the study endpoint (B ≥ 66%) during the third 
control visit, the time to complete organisation of oblit-
erating material could be only estimated as more than 
21 days (Figure 3).
Figure 1. Obliterating material whose elastographic structure was classified as (A) elastic (age 7 days – predominance of red areas), (B) mixed, fibro-elastic 
(age 14 days – predominance of green areas), and (C) fibrous (age 21 days – predominance of blue areas)
A B
C
Figure 2. Time after which obliterating material reached mixed, fibro-elastic 



















































Figure 3. Time to complete organisation of obliterating material – results 
of probit regression analysis
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Discussion
The aim of this study was to verify if elastography may 
provide information about the age of venous obliterating 
material formed after sclerotherapy procedure. The age of 
the obliterating material was estimated based on a rela-
tive area covered by the least elastic tissues (highlighted 
in blue). We chose the areas highlighted in blue because 
monitoring their relative size during consecutive control 
visits seemed to be the easiest. The relative contribution of 
blue areas increased significantly with the age of obliterat-
ing material, and changes in this parameter were marked-
ly more evident than in the case of the areas highlighted 
in red. Although the latter parameter underwent a signif-
icant reduction over time, the dynamics of this process 
varied considerably from patient to patient. Importantly, 
similar individual variability was not observed in the case 
of blue areas (Table 1). Using the abovementioned ap-
proach, the character of the obliterating material at seven 
days post-sclerotherapy was classified as elastic in all the 
cases. However, the structure of the obliterating material 
underwent substantial changes during subsequent control 
visits; at 14 days post-sclerotherapy, obliterating material 
was classified as fibro-elastic or fibrous in 60% of the study 
subjects, and none of the elastograms obtained at 21 days 
showed the presence of an elastic obliterating material.
Our findings are consistent with the results of previous 
studies using elastography to estimate the age of venous 
thrombosis. Emelianov et al. [24] were the first to use this 
method to determine the age of experimentally induced 
thrombosis in rat inferior vena cava. They showed that the 
hardness of venous thrombi increased significantly with 
time from the induction [24]. These findings were later 
confirmed by Xie et al. [26], who analysed elastographic 
characteristics of 3- to 10-day-old thrombi induced in rat 
inferior vena cava. The same study demonstrated a strong 
positive correlation between the true and elastographical-
ly-estimated age of venous thrombi [26]. One year later 
the same authors [27] conducted a similar experiment, 
showing that the Young modulus determined elasto-
graphically in rat vena cava with experimentally induced 
thrombosis correlated with the same parameter meas-
ured in a mechanical ex vivo model, but solely for throm-
bi older than 10 days [27]. This implies that dynamics of 
thrombus remodelling may change over time and is not 
necessarily fully consistent with theoretical assumptions. 
This hypothesis was later confirmed by Geier et al. [25], 
who showed that remodelling of experimentally induced 
thrombi in porcine iliac veins reached its peak levels be-
tween six and 12 days post-formation [25]. Our findings 
are partially consistent with this observation because re-
modelling of obliterating material analysed in our study 
seemed to be markedly more intensive at 7-14 days than 
at 14-21 days.
We used probit logistic regression to estimate when 
the obliterating material had lost its elastic character and 
had undergone various degrees of fibrosis. The time after 
which the obliterating material reached mixed, fibro-elas-
tic character (relative contribution of blue areas of at least 
33% but no more than 66% of vessel cross-section) was 
estimated at 14.3 days (Figure 2). The follow-up period 
of this study (21 days) turned out to be too short to esti-
mate the time to complete organisation of the obliterating 
material (Figure 3). The first attempt to estimate the age 
of venous thrombosis based on its elastographic parame-
ters was undertaken by Xie et al. [26]. According to these 
authors, experimentally-induced thrombi in rat inferior 
vena cava reached complete maturation after approxi-
mately six days, which in their opinion corresponded to 
ca. 15 days in humans [26]. This hypothesis was partially 
confirmed in elastographic studies conducted by Rubin 
et al. [14,21]. In their first study, including two patients 
with deep vein thrombosis, older venous thrombi were 
shown to be more homogeneous and less elastic [21]. 
These findings were later confirmed in a markedly larg-
er sample, including 26 patients with acute thrombosis 
and 28 individuals with chronic thrombosis [14]. This 
evidence was reflected in current therapeutic guidelines 
according to which invasive therapy of venous thrombosis 
should be undertaken no later than 14 days from its pre-
sumable onset [7,8]. Our findings correspond well with 
the results of previous studies. Obliterating the character 
of which was classified as mixed on the basis of its elas-
tographic parameters, probably corresponded to partially 
mature thrombus, in the case of which radical treatment 
is no longer recommended. This hypothesis was further 
supported by the fact that the age to partial organisation 
of the obliterating material estimated on the basis of pro-
bit regression analysis approximated the cut-off value of 
14-15 days proposed by other authors [7,8,26]. In turn, 
our observation that the time to complete organisation 
of the obliterating material was longer than 21 days is 
to a large extent consistent with the results published by 
Rubin et al. [21], according to whom thrombi older than 
25 days may still undergo a partial fibrosis.
Limitations
Analysing the results of this study, one should remember 
that it was not conducted among patients with venous 
thrombosis, but in individuals subjected to sclerothera-
py. Therefore, our presented findings cannot necessarily 
be directly transposed onto the population of patients 
with venous thrombosis. Nevertheless, sclerotherapy 
seems to be the best clinical model for venous thrombo-
sis with known age [28]. Also, the fact that we estimated 
the age of the obliterating material based on the areas 
highlighted in blue may constitute a potential limita-
tion of this study. Perhaps the results would be slightly 
different if the areas in other colour were considered as 
a measure of obliterating material age. Our rationale to 
choose blue areas, rather than those in another colour, 
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has already been presented in this section. Another po-
tential limitation can be too short follow-up. To guar-
antee comfort of our patients, we did not schedule the 
first control visit earlier than 6-8 days post-sclerother-
apy. Therefore, we were unable to analyse remodelling 
of the obliterating material at the earliest stages. How-
ever, available evidence suggests that elastographical-
ly-determined remodelling of venous thrombus during 
the first six days is less intensive [25]. This observation 
was also confirmed in our study because the character 
of the obliterating material during the first control visit 
was classified as elastic in all the cases. Because we fol-
lowed-up our patients for no more than 21 days, we were 
also unable to determine the exact time to complete or-
ganisation of the obliterating material. Nevertheless, our 
findings suggest that the time point at which the struc-
ture of the obliterating material changed from elastic to 
mixed (fibro-elastic) is more important from a clinical 
perspective; presumably, this time point corresponds to 
transition from acute to chronic thrombosis.
Even considering all the potential limitations men-
tioned above, the presented findings imply that ultra-
sound elastography with semiquantitative evaluation of 
the obliterating material can accurately determine the 
age of venous thrombi. The economic burden of venous 
thrombosis and its complications is huge; treatment costs 
of this condition in the United States amount to 15,000-
25,000 USD per patient [29]. Taking into account that 
a large proportion of complications result from inaccurate 
assessment of thrombus age, routine use of an inexpensive 
and reproducible diagnostic instrument, such as elastog-
raphy, for this purpose might produce not only have med-
ical but also economic benefits.
Conclusions
Changes occurring with time in the structure of venous 
obliterating material formed during polidocanol sclero-
therapy are accurately reflected by the results of ultra-
sound elastography. Fourteen days after its formation, the 
obliterating material presents on elastography as a mixed, 
fibro-elastic structure, presumably corresponding to 
chronic thrombus. However, time to complete organisa-
tion of the obliterating material is longer than 21 days.
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